Results 1 to 10 of about 1,819,338 (169)

Left Ventricular Physiology and Ventricular‐Vascular Interactions in Young Patients After Heart Transplantation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background In patients after heart transplantation, systemic arterial hypertension and enhanced central aortic stiffness contribute to increased ventricular afterload, which might lead to graft dysfunction.
Heiner Latus, Ramona Raap, Karin Klingel, Christoph Happel, Axel Moysich, Markus Khalil, Gunter Kerst, Jakob Milla, Susanne Skrzypek, Josef Thul, Christian Jux, Dietmar Schranz, Christian Apitz   +12 more
doaj   +1 more source

Application of Transesophageal Echocardiography in Amplatzer Atrial Septal Defect Occluder for Percutaneous Closure of Large Patent Foramen Ovale

Cardiovascular Therapeutics, 2022
Objective. The Amplatzer patent foramen ovale (PFO) occluder is the most commonly used device for percutaneous closure of a large PFO. However, its use may predispose the patient to postoperative residual shunting.
Yajuan Du, Hang Xie, Hui Shao, Gesheng Cheng, Lu He, Xingye Wang, Xumei He, Beidi Lan, Yushun Zhang, Gang Tian   +9 more
doaj   +1 more source

Pulmonary hypertension— a novel phenotypic hypothesis of Kabuki syndrome: a case report and literature review

BMC Pediatrics, 2023
Background Pediatric pulmonary hypertension (PH) is a serious and rare disease that is often derived from genetic mutations. Kabuki syndrome (KS) is a chromosomal abnormality disease that has its origin in the mutation of lysine methyltransferase 2D ...
Xiao-xian Deng, Bo-wen Jin, Shan-shan Li, Hong-mei Zhou, Qun-shan Shen, Yun-yan Li   +5 more
doaj   +1 more source

Risk of malignancy long after acute coronary syndrome in selected urban and rural areas and comparison with smoking risk: the ABC-7* study on Heart Disease

Cardio-Oncology, 2021
Background Increased cancer risk has been reported in patients with acute coronary syndrome (ACS). Objectives To investigate geographic differences in risk malignancy long after ACS.
Giuseppe Berton, Heba T. Mahmoud, Rosa Palmieri, Fiorella Cavuto, Rocco Cordiano, Elisabetta Lorenzon, Francesco Bagato   +6 more
doaj   +1 more source

Where the congenital heart disease meets the pulmonary arterial hypertension, FLNA matters: a case report and literature review

BMC Pediatrics, 2020
Background Pediatric patients with genetic disorders have a higher incidence of pulmonary arterial hypertension (PAH) regardless of their heart defects. Filamin A (FLNA) mutation is recently recognized to be associated with pediatric pulmonary disorders,
Xiaoxian Deng, Shanshan Li, Qiu Qiu, Bowen Jin, Menghuan Yan, Yuanpin Hu, Yang Wu, Hongmei Zhou, Gangcheng Zhang, Xuan Zheng   +9 more
doaj   +1 more source

Bile acid predicts congenital portosystemic venous shunt in patients with pulmonary arterial hypertension

European Journal of Medical Research, 2023
The etiology of pulmonary arterial hypertension (PAH) is complex, especially the investigation of rare pathogeny is difficult. Congenital portosystemic venous shunt (CPSS) is a rare congenital anomaly in which the portal blood completely or partially ...
Yunyan Li, Xiaoxian Deng, Hongmei Zhou, Xuan Zheng, Gangcheng Zhang, Qingfeng Xiong   +5 more
doaj   +1 more source

Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting for Chronic Total Occlusion of Coronary Arteries: A Systematic Review and Meta-Analysis

Journal of Interventional Cardiology, 2023
Introduction. Chronic total occlusion (CTO) of coronary arteries constitutes a substantial clinical challenge and has historically been managed through medical management and coronary artery bypass grafting (CABG).
Chenyang Wang, Sheng Liu, Raimov Kamronbek, Siyao Ni, Yunjiu Cheng, Huiyuan Yan, Ming Zhang   +6 more
doaj   +1 more source

Wearable cardioverter-defibrillator (life-vest): A feasible bridging treatment in adult congenital heart disease

Indian Pacing and Electrophysiology Journal, 2022
Background: Wearable cardioverter-defibrillators (WCDs) are currently used in patients at temporarily heightened risk for sudden cardiac death (SCD) who are temporarily unable to receive an implantable cardioverter-defibrillator (ICD).
Berardo Sarubbi, Michela Palma, Assunta Merola, Flavia Fusco, Anna Correra, Diego Colonna, Emanuele Romeo, Nicola Grimaldi, Giovanni Domenico Ciriello, Giancarlo Scognamiglio, Maria Giovanna Russo   +10 more
doaj   +1 more source

Long‐Term Outcomes of Patients With Mediastinal Radiation–Associated Severe Aortic Stenosis and Subsequent Surgical Aortic Valve Replacement: A Matched Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
Background Cardiac disease after mediastinal radiotherapy for thoracic malignancy (chest radiotherapy [XRT]) often manifests as progressive aortic stenosis. In patients with XRT‐induced severe aortic stenosis undergoing surgical aortic valve replacement (
Eoin Donnellan, Ahmad Masri, Douglas R. Johnston, Gosta B. Pettersson, L. Leonardo Rodriguez, Zoran B. Popovic, Eric E. Roselli, Nicholas G. Smedira, Lars G. Svensson, Brian P. Griffin, Milind Y. Desai   +10 more
doaj   +1 more source

Impact of transcatheter aortic valve implantation on left ventricular function recovery, mass regression and outcome in patients with aortic stenosis: protocol of the TAVI-NOR prospective study

BMJ Open, 2021
Introduction Transcatheter aortic valve implantation (TAVI) is a widely used treatment option as an alternative to surgical aortic valve replacement in patients with severe aortic stenosis (AS) at high or intermediate surgical risk.
Sahrai Saeed, Svein Rotevatn, Abukar Mohamed Ali, Daanyaal Wasim, Kjetil Halvorsen Løland, Øyvind Bleie   +5 more
doaj   +1 more source